Investor's Business Daily on MSN13m
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial ResultsNovo Nordisk reported strong early-stage results for its once-a-week obesity drug. Early Friday, Novo Nordisk stock jumped. Eli Lilly fell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback